Global Liquid Biopsy Market Report 2021-2028 Featuring Qiagen, F. Hoffmann-La Roche, Bio-Rad Laboratories, Illumina, Inivata, Agena Bioscience, Thermo Fisher Scientific, Guardant Health
Global Liquid Biopsy Market Report 2021-2028 Featuring Qiagen, F. Hoffmann-La Roche, Bio-Rad Laboratories, Illumina, Inivata, Agena Bioscience, Thermo Fisher Scientific, Guardant Health
DUBLIN, Sept. 24, 2021 /PRNewswire/ -- The "Global Liquid Biopsy Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering.
都柏林9月2021年2月24日/美通社/--《2028年全球液體活檢市場展望》報告新增至Research andMarkets.com的獻祭。
The global liquid biopsy market attained revenue of close to USD 3160 Million in 2019 and is estimated to garner over USD 25800 Million in 2028.
2019年，全球液體活檢市場的收入接近3.16億美元，預計將超過2.58億美元在2028年。
The global liquid biopsy market is anticipated to grow with a CAGR of 30.7% during the forecast period, i.e., 2020-2028.
預計在2020-2028年的預測期內，全球液體活檢市場將以30.7%的複合年增長率增長。
Factors such as the growing incidences of cancer, followed by the rise in research and developments in the field of medical sciences, are estimated to drive the market growth. In the year 2020, globally, 19.3 Million cancer cases were registered, according to the statistical report GLOBOCAN 2020, released by the International Agency for Research on Cancer (IARC).
據估計，癌症發病率不斷上升，以及醫學領域研究和開發的增加等因素，將推動市場增長。根據國際癌症研究機構(IARC)發佈的統計報告GLOBOCAN 2020,2020年，全球登記了1930萬癌症病例。
Owing to the rise in cancer cases, the need for early diagnostic and treatment is growing at a significant pace, which is anticipated to create opportunities for market growth. Further, growing need for minimally invasive or non-invasive medical processes, and the increasing investments of government of nations to promote advancements in the field of medical sciences are also expected to contribute to the market growth.
由於癌症病例的增加，對早期診斷和治療的需求正在以顯著的速度增長，預計這將為市場增長創造機會。此外，對微創或非侵入性醫療過程的日益增長的需求，以及各國政府為促進醫學領域的進步而增加的投資，預計也將有助於市場的增長。
The market is segmented into numerous segments, which include segmentation by product, biomarker type, sample, clinical application, disease indication, end-user, and by region. Based on product type, the market is segmented into tools, assay kits & reagents, and services. Out of these segments, the tools segment is estimated to hold the highest share of close to 70% in 2021 and further garner around USD 17800 Million by the end of 2028.
市場細分為許多細分市場，包括產品細分、生物標誌物類型細分、樣本細分、臨牀應用細分、疾病適應症細分、終端用户細分和地區細分。根據產品類型，市場被細分為工具、檢測試劑和試劑以及服務。在這些細分市場中，預計2021年工具部門的份額最高，接近70%，到2028年底將進一步獲得約178億美元的收入。
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, out of which, the market in the North America is estimated to hold the leading market share of 36% approximately and attain a revenue of over USD 9300 Million by the end of 2028.
根據地區，市場被細分為北美，歐洲，亞太地區，拉丁美洲，和中東&非洲其中，北美市場估計佔據了大約36%的領先市場份額，實現了超過36%的收入9.3億美元到2028年底。
Some of the key players in the global liquid biopsy market that are mentioned in our report are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Illumina, Inc., Inivata Limited, Agena Bioscience, Inc., Thermo Fisher Scientific, Guardant Health, Inc. and others.
在我們的報告中提到的一些全球液體活檢市場的主要參與者包括Qiagen，F.Hoffmann-La Roche Ltd，Bio-Rad Laboratory，Inc.，Illumina，Inivata Limited，Agena Bioscience，Inc.，Thermo Fisher Science，Guardant Health，Inc.等。
Key Topics Covered:
1. Market Definition
1.1 Market Definition
1.2 Market Segmentation
1.3 Product Overview
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary research
2.4 Market size estimation
3. Executive Summary- Global Liquid Biopsy Market
4. Analysis of Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Trends
5. Regulatory & Standards Landscape
6. Pricing Analysis
7. Epidemiology Analysis
8. Impact of COVID-19 on the Liquid Biopsy Market
8.1 Pre-COVID-19 Scenario, 2017-19
8.2 COVID-19 scenario, 2020
8.3 Post-COVID-19 scenario
9. Comparative Analysis (Liquid biopsy vs Tissue-based biopsy)
10. End-User Usability Analysis
11. Competitive Structure
12. Global Liquid Biopsy Market Outlook
12.1 Global Liquid Biopsy Market Segmentation Analysis 2019-2028
12.1.1 By Product, 2019-2028F (in USD Million)
12.1.1.1 Tools, 2019-2028F (USD Million)
12.1.1.1.1 Next generation sequencing (NGS), 2019-2028F (USD Million)
12.1.1.1.2 Polymerase chain reaction (PCR), 2019-2028F (USD Million)
12.1.1.1.3 Microarrays, 2019-2028F (USD Million)
12.1.1.2 Assay kits & reagents, 2019-2028F (USD Million)
12.1.1.3 Services, 2019-2028F (USD Million)
12.1.2 By Biomarker Type, 2019-2028F (in USD Million)
12.1.2.1 Circulating Tumor Cells, 2019-2028F (USD Million)
12.1.2.2 Circulating Tumor DNA, 2019-2028F (USD Million)
12.1.2.3 Exosomes, 2019-2028F (USD Million)
12.1.2.4 Circulating RNA & Proteins, 2019-2028F (USD Million)
12.1.2.5 Nucleosomes, 2019-2028F (USD Million)
12.1.3 By Sample, 2019-2028F (in USD Million)
12.1.3.1 Blood, 2019-2028F (USD Million)
12.1.3.2 Urine, 2019-2028F (USD Million)
12.1.3.3 Others, 2019-2028F (USD Million)
12.1.4 By Clinical Application, 2019-2028F (in USD Million)
12.1.4.1 Early Disease Screening, 2019-2028F (USD Million)
12.1.4.2 Therapy Selection, 2019-2028F (USD Million)
12.1.4.3 Treatment Response Monitoring, 2019-2028F (USD Million)
12.1.4.4 Molecular Health Monitoring, 2019-2028F (USD Million)
12.1.4.5 Others, 2019-2028F (USD Million)
12.1.5 By Disease Indication, 2019-2028F (in USD Million)
12.1.5.1 Lung Cancer, 2019-2028F (USD Million)
12.1.5.2 Colorectal Cancer, 2019-2028F (USD Million)
12.1.5.3 Breast Cancer, 2019-2028F (USD Million)
12.1.5.4 Prostate Cancer, 2019-2028F (USD Million)
12.1.5.5 Liver Cancer, 2019-2028F (USD Million)
12.1.5.6 Head & Neck Cancer, 2019-2028F (USD Million)
12.1.5.7 Others, 2019-2028F (USD Million)
12.1.6 By End-User, 2019-2028F (in USD Million)
12.1.6.1 Hospitals, 2019-2028F (USD Million)
12.1.6.2 Clinics, 2019-2028F (USD Million)
12.1.6.3 Research Laboratories, 2019-2028F (USD Million)
12.1.6.4 Academic Institutes, 2019-2028F (USD Million)
12.1.6.5 Others, 2019-2028F (USD Million)
12.1.7 By Region, 2019-2028F (in USD Million)
13. North America Liquid Biopsy Market Outlook
14. Latin America Liquid Biopsy Market Outlook
15. Europe Liquid Biopsy Market Outlook
16. Asia Pacific Liquid Biopsy Market Outlook
17. Middle East & Africa Liquid Biopsy Market Outlook
18. Competitive Structure
涵蓋的主要主題： 1.市場定義1.1市場定義1.2市場細分1.3產品概述二、研究方法2.1研究流程2.2初步研究2.3二級研究2.4市場規模估算3.執行摘要-全球液體活檢市場4.市場動態分析4.1驅動程序4.2約束4.3機會4.4趨勢5.法規和標準景觀6.價格分析7.流行病學分析8、新冠肺炎對液體活檢市場的影響8.1新冠肺炎之前的場景，2017-19年8.2新冠肺炎場景，20208.3後新冠肺炎場景9.對比分析(液體活檢與組織活檢)10.終端用户可用性分析11.競爭格局12.全球液體活檢市場展望12.1 2019-2028年全球液體活檢市場細分分析12.1.1按產品劃分，2019-2028F(百萬美元)12.1.1.1工具，2019-2028F(百萬美元)12.1.1.1.1下一代排序(NGS)，2019-2028F(百萬美元)12.1.1.1.2聚合酶鏈式反應(PCR)，2019-2028F(百萬美元)12.1.1.1.3微陣列，2019-2028F(百萬美元)12.1.1.2試劑盒和試劑，2019-2028F(百萬美元)12.1.1.3服務，2019-2028F(百萬美元)12.1.2按Biomarker Type，2019-2028F(單位：百萬美元)12.1.2.1循環腫瘤細胞，2019-2028F(百萬美元)12.1.2.2循環腫瘤DNA，2019-2028F(百萬美元)12.1.2.3外切體，2019-2028F(百萬美元)12.1.2.4循環RNA和蛋白質，2019-2028F(百萬美元)12.1.2.5核小體，2019-2028F(百萬美元)12.1.3樣本，2019-2028F(百萬美元)12.1.3.1血液，2019年-2028F(百萬美元)12.1.3.2尿液，2019年-2028F(百萬美元)12.1.3.3其他，2019-2028F(百萬美元)12.1.4按臨牀應用，2019-2028F(百萬美元)12.1.4.1疾病早期篩查，2019-2028F(百萬美元)12.1.4.2治療選擇，2019-2028F(百萬美元)12.1.4.3治療反應監測，2019-2028F(百萬美元)12.1.4.4分子健康監測，2019-2028F(百萬美元)12.1.4.5其他，2019-2028F(百萬美元)12.1.5按疾病適應症劃分，2019-2028F(單位：百萬美元)12.1.5.1肺癌，2019-2028F(百萬美元)12.1.5.2結直腸癌，2019-2028F(百萬美元)12.1.5.3乳腺癌，2019-2028F(百萬美元)12.1.5.4前列腺癌，2019-2028F(百萬美元)12.1.5.5肝癌，2019-2028F(百萬美元)12.1.5.6頭頸部癌症，2019-2028F(百萬美元)12.1.5.7其他，2019-2028F(百萬美元)12.1.6按最終用户劃分，2019-2028F(百萬美元)12.1.6.1醫院，2019-2028F(百萬美元)12.1.6.2診所，2019-2028F(百萬美元)12.1.6.3研究實驗室，2019-2028F(百萬美元)12.1.6.4學術機構，2019-2028F(百萬美元)12.1.6.5其他，2019-2028F(百萬美元)12.1.7按地區劃分，2019-2028F(單位：百萬美元)13、北美液體活檢市場展望14.拉丁美洲液體活檢市場展望15.歐洲液體活檢市場展望16.亞太液體活檢市場展望17. 中東非洲液體活檢市場展望18.競爭格局
- Qiagen
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Inivata Limited
- Agena Bioscience Inc.
- Thermo Fisher Scientific
- Guardant Health Inc.
- 恰根
- 霍夫曼-拉羅氏有限公司
- Bio-Rad實驗室公司
- Illumina。
- Inivata Limited
- Agena Bioscience Inc.
- Thermo Fisher Science
- Guardant Health Inc.
For more information about this report visit https://www.researchandmarkets.com/r/wj8qhz
有關本報告的更多信息，請訪問https://www.researchandmarkets.com/r/wj8qhz。
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
媒體聯繫人： 研究和市場勞拉·伍德(Laura Wood)，高級經理[受電子郵件保護]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
對於E.S.T辦公時間，請撥打電話：+1-917-300-0470美國/加拿大免費電話：+1-800-526-8630對於格林尼治標準時間辦公時間，請致電+353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
美國傳真：646-607-1904傳真(美國境外)：+353-1-481-1716
SOURCE Research and Markets
來源研究和市場
Related Links
相關鏈接
http://www.researchandmarkets.com
Http://www.researchandmarkets.com
譯文內容由第三人軟體翻譯。